gentron logo mix
l2
home company developments genomc services investor relations
contact us
l
 
   
  company overview
  team
  management
  scientific team
   
   
   

 

Management
Marcelo Markous
Marcelo Markous
CEO & President

"Building a team of top scientists coming from a number of different disciplines is very exiting and rewarding. Our aim is to capitalize on the enormous changes in genetics research. Biotechnology is surely one of the most dynamic areas as we move forward into the new millennium. I see in Gentron a company on the verge of making enormous strides within an industry currently positioned to reshape and redefine our lives. Gentron’s researchers energy, creativity, background, and achievements in applied research will contribute to the development of unique products that will impact the medical field, generating healthy returns for our shareholders. Gentron is positioned to become a leading force in biotechnology."

Marcelo is an engineer with a strong background in finance and management. He has been associated with many private companies and for the last 5 years has been running his own companies. Marcelo is one of Gentron ’s earliest shareholders.

 

Martín Bercetche
Martin Bercetche, M.D.
Commercial Director

 “I am thrilled to be working with Gentron in such an innovative and interesting project. I hope that our approach will aid doctors in making early cancer diagnosis and at the same time, benefitting a larger number of cancer sufferers".

Martin is a medical doctor from the School of Medicine, University of Buenos Aires . He brings to Gentron an extensive pharmaceutical business experience. During his 30 years career with Pfizer, Martin worked for sixteen years in the New York Headquarters. He was initially responsible for medical operations in Latin America, Asia(including Japan), Africa and the Middle East.

In 1995, Martin moved to the business side and took on different Marketing and Sales responsibilities for Japan , Korea and Australia. He retired in 2003 as Director, Pharmaceutical Business for Europe and Canada. Since then, Martin is back in Argentina with his family and in 2004 became a shareholder and commercial director
for Gentron.

 

 

davidovich
Carlos Davidovich, M.D.
External Comercial Advisor

“Since the moment the project was presented to me I recognized that a breakthrough was happening. I had the honour to be one of the first to join Gentron and lead it in its launching.

Through my own work experience as a medical doctor and as a business man in pharmaceuticals companies I was able to realize the transcendence of Gentron.

The combination of top scientific researchers working in the forefront of Biotechnology together with an outstanding vision only can lead to outcomes that will definitely open new doors in the understanding of processes that will allow news approaches in the world of diagnostic and therapy.

Gentron became the concrete possibility to materialize scientific evidence of a concept that was “in the air” but required the confirmation to enable not predictable routes of multiplication. It has the key, and is giving the chance to science as well as to business to make a quantum leap to a new level of achievements.

I have learned that proactiviness is the shortcut to results; Gentron´s project is about early diagnosis in a range of life threatening diseases. This approach will give the opportunity to be ahead, to be able to change what has until now been known as natural trends of diseases.".


Carlos is medical doctor and worked for more than 20 years leading the Biotech business in Multinational Corporations as Hoffman-LaRoche, Pharmacia Inc, and others.  He was in charge of the areas of Sales, Marketing and R&D in Biotech Business Units and had the opportunity to be part of the launching of the tops biotech products that had hit the market. Now he is living in Madrid with his family and is in charge of Commercial activities of Gentron.

 

 
 
t2
t

Home
The Company
Developments
Genomic Services
Investors Relations
Contact Us
Site Map